Dennis Bastas is the Executive Chairman and CEO of the Arrotex Australia Group of companies and Chairman of Juno Pharmaceuticals. In 2015, Dennis acquired the Arrow business, in partnership with Strides Pharmaceuticals, from Aspen Pharmaceuticals. After buying out the Strides ownership in 2019, he merged the business with Apotex Australia to form Arrotex Pharmaceuticals. Prior to this, Dennis founded Ascent Pharmaceuticals and as CEO went on to build a successful Australian and Asian generic pharmaceutical company which was ultimately sold to Actavis Pharmaceuticals. Dennis also developed the Central Healthcare group of companies in 2010, which he sold to Sigma Pharmaceuticals in 2014. Dennis is also the major shareholder and Chairman of myDNA, a world leading pharmacogenomic and health genomic platform technology.

Chairman & Group CEO, Arrotex Australia Group


DENNIS BASTAS

Session:

Alan Russell Oration: Global search for innovation
– learnings for Community Pharmacy in Australia

When:

Thursday 19 March, 12.15pm –1.00pm

Proudly sponsored by:

SESSION SPONSOR

PROGRAM SPONSOR

MAJOR SPONSOR

VIEW ALL

PRINCIPAL SPONSOR

APP2020 SPONSORS

© 2022 APP Conference. All Rights Reserved.

The 2022 Australian Pharmacy Professional Conference is proudly sponsored by:

SESSION SPONSORS

PROGRAM SPONSORS

MAJOR SPONSORS

PRINCIPAL SPONSORS

APP2022 SPONSORS

FOLLOW US

SPONSORSHIP & TRADE

(c) 2021 APP Conference 2022. All Rights Reserved.

LATEST NEWS

#APP2022

Events Division

The Pharmacy Guild of Australia

Queensland Branch

OFFICIAL EVENT PARTNER

07 3831 9246

SITE CREDITS

CONTACT US

APP Sand 1

AA8730

APP OCEAN 3

2F7A81

APP OCEAN 2

347D83

GOLD

D3A94A

TEAL 

4AB9B7